498 related articles for article (PubMed ID: 20182843)
1. Diagnostic performance of fluorodeoxyglucose positron emission tomography/magnetic resonance imaging fusion images of gynecological malignant tumors: comparison with positron emission tomography/computed tomography.
Nakajo K; Tatsumi M; Inoue A; Isohashi K; Higuchi I; Kato H; Imaizumi M; Enomoto T; Shimosegawa E; Kimura T; Hatazawa J
Jpn J Radiol; 2010 Feb; 28(2):95-100. PubMed ID: 20182843
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous positron emission tomography/magnetic resonance imaging for whole-body staging in patients with recurrent gynecological malignancies of the pelvis: a comparison to whole-body magnetic resonance imaging alone.
Grueneisen J; Beiderwellen K; Heusch P; Gratz M; Schulze-Hagen A; Heubner M; Kinner S; Forsting M; Lauenstein T; Ruhlmann V; Umutlu L
Invest Radiol; 2014 Dec; 49(12):808-15. PubMed ID: 25010207
[TBL] [Abstract][Full Text] [Related]
3. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
[TBL] [Abstract][Full Text] [Related]
4. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
[TBL] [Abstract][Full Text] [Related]
5. Detectability of Malignant Lesions by Whole-Body Magnetic Resonance Imaging Using Whole-Body Integrated Positron Emission Tomography/Magnetic Resonance Imaging.
Ishii S; Miyajima M; Suenaga H; Sugawara S; Nemoto A; Ukon N; Nambu T; Kubo H; Oriuchi N; Ito H
J Comput Assist Tomogr; 2019; 43(4):664-670. PubMed ID: 31259851
[TBL] [Abstract][Full Text] [Related]
6. The usefulness of (18)F-FDG PET/MRI fusion image in diagnosing pancreatic tumor: comparison with (18)F-FDG PET/CT.
Nagamachi S; Nishii R; Wakamatsu H; Mizutani Y; Kiyohara S; Fujita S; Futami S; Sakae T; Furukoji E; Tamura S; Arita H; Chijiiwa K; Kawai K
Ann Nucl Med; 2013 Jul; 27(6):554-63. PubMed ID: 23580090
[TBL] [Abstract][Full Text] [Related]
7. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
Xin J; Ma Q; Guo Q; Sun H; Zhang S; Liu C; Zhai W
Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET/MRI fusion in characterizing pancreatic tumors: comparison to PET/CT.
Tatsumi M; Isohashi K; Onishi H; Hori M; Kim T; Higuchi I; Inoue A; Shimosegawa E; Takeda Y; Hatazawa J
Int J Clin Oncol; 2011 Aug; 16(4):408-15. PubMed ID: 21347626
[TBL] [Abstract][Full Text] [Related]
9. The impact of image fusion in resolving discrepant findings between FDG-PET and MRI/CT in patients with gynaecological cancers.
Tsai CC; Tsai CS; Ng KK; Lai CH; Hsueh S; Kao PF; Chang TC; Hong JH; Yen TC
Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1674-83. PubMed ID: 12937950
[TBL] [Abstract][Full Text] [Related]
10. Value of fusion of PET and MRI in the detection of intra-pelvic recurrence of gynecological tumor: comparison with 18F-FDG contrast-enhanced PET/CT and pelvic MRI.
Kitajima K; Suenaga Y; Ueno Y; Kanda T; Maeda T; Makihara N; Ebina Y; Yamada H; Takahashi S; Sugimura K
Ann Nucl Med; 2014 Jan; 28(1):25-32. PubMed ID: 24129541
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
[TBL] [Abstract][Full Text] [Related]
12. 18F-FDG-PET and MRI in patients with malignancies of the liver and pancreas. Accuracy of retrospective multimodality image registration by using the CT-component of PET/CT.
Donati OF; Reiner CS; Hany TF; Fornaro J; von Schulthess GK; Marincek B; Weishaupt D
Nuklearmedizin; 2010; 49(3):106-14. PubMed ID: 20407733
[TBL] [Abstract][Full Text] [Related]
13. Improving liver lesion characterisation using retrospective fusion of FDG PET/CT and MRI.
Parsai A; Miquel ME; Jan H; Kastler A; Szyszko T; Zerizer I
Clin Imaging; 2019; 55():23-28. PubMed ID: 30710749
[TBL] [Abstract][Full Text] [Related]
14. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
15. Optimizing positron emission tomography image acquisition protocols in integrated positron emission tomography/magnetic resonance imaging.
Hartung-Knemeyer V; Beiderwellen KJ; Buchbender C; Kuehl H; Lauenstein TC; Bockisch A; Poeppel TD
Invest Radiol; 2013 May; 48(5):290-4. PubMed ID: 23399811
[TBL] [Abstract][Full Text] [Related]
16. Improving MR sequence of 18F-FDG PET/MR for diagnosing and staging gastric Cancer: a comparison study to
Zheng D; Liu Y; Liu J; Li K; Lin M; Schmidt H; Xu B; Tian J
Cancer Imaging; 2020 Jun; 20(1):39. PubMed ID: 32546207
[TBL] [Abstract][Full Text] [Related]
17. Retrospective interactive rigid fusion of (18)F-FDG-PET and CT. Additional diagnostic information in melanoma patients.
Römer W; Nömayr A; Greess H; Fiedler E; Platsch G; Schuler-Thurner B; Pfahlberg A; Hothorn T; Schuler G; Hornegger J; Bautz W; Kuwert T
Nuklearmedizin; 2006; 45(2):88-95. PubMed ID: 16547570
[TBL] [Abstract][Full Text] [Related]
18. Value of fusion of PET and MRI for staging of endometrial cancer: comparison with ¹⁸F-FDG contrast-enhanced PET/CT and dynamic contrast-enhanced pelvic MRI.
Kitajima K; Suenaga Y; Ueno Y; Kanda T; Maeda T; Takahashi S; Ebina Y; Miyahara Y; Yamada H; Sugimura K
Eur J Radiol; 2013 Oct; 82(10):1672-6. PubMed ID: 23727380
[TBL] [Abstract][Full Text] [Related]
19. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of PET/CT versus PET/MRI in gynecological malignancies of the pelvis: A meta-analysis.
Virarkar M; Ganeshan D; Devine C; Bassett R; Kuchana V; Bhosale P
Clin Imaging; 2020 Mar; 60(1):53-61. PubMed ID: 31864201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
